Holen Sie sich die Stockscreener-App
27.09
3.12%
0.82
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ADNT?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$26.27
Offen:
$26.38
24-Stunden-Volumen:
1.31M
Relative Volume:
1.07
Marktkapitalisierung:
$2.12B
Einnahmen:
$14.69B
Nettoeinkommen (Verlust:
$18.00M
KGV:
117.78
EPS:
0.23
Netto-Cashflow:
$277.00M
1W Leistung:
+2.38%
1M Leistung:
+26.29%
6M Leistung:
+12.78%
1J Leistung:
+57.41%
1-Tages-Spanne:
$26.27
$27.32
1-Wochen-Bereich:
$25.53
$27.32
52-Wochen-Spanne:
$10.04
$27.32
Adient Plc Stock (ADNT) Company Profile
Firmenname
Adient Plc
Sektor
Branche
Telefon
1-734-254-5000
Adresse
25 NORTH WALL QUAY, DUBLIN
Compare ADNT vs ORLY, AZO, GPC, MGA, APTV
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ADNT
Adient Plc
|
27.09 | 2.06B | 14.69B | 18.00M | 277.00M | 0.23 |
|
ORLY
Oreilly Automotive Inc
|
96.66 | 80.16B | 17.78B | 2.54B | 1.59B | 2.9631 |
|
AZO
Autozone Inc
|
3,858.16 | 62.77B | 19.29B | 2.46B | 1.86B | 143.41 |
|
GPC
Genuine Parts Co
|
147.16 | 20.53B | 24.06B | 808.50M | 133.52M | 5.8048 |
|
MGA
Magna International Inc
|
68.73 | 16.29B | 41.79B | 1.11B | 1.67B | 3.6554 |
|
APTV
Aptiv Plc
|
85.20 | 17.66B | 19.64B | 1.56B | 1.71B | 6.04 |
Adient Plc Stock (ADNT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-05 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2026-01-14 | Hochstufung | UBS | Neutral → Buy |
| 2025-09-25 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-08-21 | Eingeleitet | Stifel | Buy |
| 2025-04-23 | Eingeleitet | Citigroup | Neutral |
| 2025-03-04 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-12-16 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-11-21 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-09-10 | Fortgesetzt | Deutsche Bank | Hold |
| 2024-09-05 | Fortgesetzt | Wolfe Research | Peer Perform |
| 2024-07-01 | Hochstufung | Exane BNP Paribas | Underperform → Neutral |
| 2024-04-10 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2023-09-13 | Eingeleitet | UBS | Neutral |
| 2023-06-01 | Herabstufung | Exane BNP Paribas | Neutral → Underperform |
| 2023-02-15 | Eingeleitet | Barclays | Overweight |
| 2023-02-09 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2023-01-09 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-11-08 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-11-07 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-04-11 | Eingeleitet | Exane BNP Paribas | Neutral |
| 2022-04-06 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2021-12-16 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-03-26 | Eingeleitet | Wells Fargo | Overweight |
| 2021-03-18 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2020-11-17 | Herabstufung | BofA Securities | Buy → Underperform |
| 2020-11-11 | Bestätigt | The Benchmark Company | Buy |
| 2020-08-12 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-08-10 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2020-05-06 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-05-06 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-04-21 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-02-12 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2020-02-03 | Hochstufung | Buckingham Research | Underperform → Neutral |
| 2020-01-31 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2020-01-27 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-01-09 | Eingeleitet | The Benchmark Company | Hold |
| 2019-10-08 | Fortgesetzt | Wolfe Research | Peer Perform |
| 2019-09-13 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-06-27 | Eingeleitet | Credit Suisse | Neutral |
| 2019-05-09 | Herabstufung | Longbow | Buy → Neutral |
| 2019-04-22 | Herabstufung | Buckingham Research | Neutral → Underperform |
| 2019-04-16 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2019-04-12 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-04-05 | Hochstufung | RBC Capital Mkts | Underperform → Sector Perform |
Alle ansehen
Adient Plc Aktie (ADNT) Neueste Nachrichten
Adient stock hits 52-week high at 27.21 USD By Investing.com - Investing.com Nigeria
Adient stock hits 52-week high at 27.21 USD - Investing.com
Can Adient plc reach resistance levels soonWeekly Investment Report & Stepwise Entry/Exit Trade Alerts - mfd.ru
Adient (NYSE:ADNT) Hits New 12-Month HighStill a Buy? - MarketBeat
Adient (NYSE:ADNT) Given Average Rating of "Hold" by Brokerages - MarketBeat
FMR LLC Significantly Reduces Holdings in Adient PLC - GuruFocus
Is Adient plc impacted by rising ratesJuly 2025 Analyst Calls & Precise Buy Zone Identification - mfd.ru
Adient (ADNT) Is Up 23.1% After Raising 2026 Revenue Outlook Despite Q1 Net Loss - simplywall.st
Will Adient plc stock see insider buyingWeekly Stock Recap & Community Supported Trade Ideas - mfd.ru
Understanding the Setup: (ADNT) and Scalable Risk - Stock Traders Daily
Adient Highlights Strong Q1 2026 Results and Outlook - TipRanks
Adient : 2026 Wolfe Research Auto, Auto Tech and Semiconductor Conference Presentation - marketscreener.com
Adient plc Reports Strong Q1 FY26 Performance - TradingView
Adient (ADNT) Sees Target Price Raise by Citigroup | ADNT Stock News - GuruFocus
Allianz Asset Management GmbH Trims Stake in Adient $ADNT - MarketBeat
Adient raises 2026 outlook to $14.6B revenue and $880M adjusted EBITDA as onshoring momentum builds - MSN
Adient stock hits 52-week high, reaching $26.16 By Investing.com - Investing.com Nigeria
Adient (NYSE:ADNT) Price Target Raised to $28.00 at JPMorgan Chase & Co. - MarketBeat
ADNT: Barclays Maintains Rating, Raises Price Target to $27 | AD - GuruFocus
Adient stock hits 52-week high, reaching $26.16 - Investing.com
Adient (NYSE:ADNT) Hits New 1-Year High Following Analyst Upgrade - MarketBeat
Adient (NYSE:ADNT) Price Target Raised to $27.00 - MarketBeat
Morgan Stanley Remains a Hold on Adient (ADNT) - The Globe and Mail
Adient price target raised to $27 from $25 at Barclays - TipRanks
Decoding Adient PLC (ADNT): A Strategic SWOT Insight - GuruFocus
Deutsche Bank upgrades Adient on ‘compelling turnaround story’ - TipRanks
Adient price target raised to $32 from $30 at UBS - TipRanks
Adient earnings beat by $0.16, revenue topped estimates - Investing.com Nigeria
Demystifying Adient: Insights From 8 Analyst Reviews - Benzinga
UBS Raises Adient (ADNT) Price Target to $32 with Buy Rating | A - GuruFocus
ADNT: Morgan Stanley Raises Price Target to $22.00, Maintains Eq - GuruFocus
Morgan Stanley Boosts Adient (NYSE:ADNT) Price Target to $22.00 - MarketBeat
Adient plc (NYSE:ADNT) Q1 2026 Earnings Call Transcript - Insider Monkey
Deutsche Bank Upgrades Adient (ADNT) Amid Promising Turnaround - GuruFocus
Deutsche Bank Upgrades Adient to Buy From Hold, Adjusts Price Target to $33 From $26 - marketscreener.com
Adient Q1 2026 Results: Loss Reported but Beats Revenue, EPS ForecastsNews and Statistics - IndexBox
Adient (NYSE:ADNT) Upgraded by Deutsche Bank Aktiengesellschaft to "Buy" Rating - MarketBeat
Adient earnings beat by $0.16, revenue topped estimates By Investing.com - Investing.com South Africa
Adient Q1 Earnings Call Highlights - MarketBeat
Adient Q1 2026 Earnings Call Transcript - MarketBeat
Adient plc Earnings Call: Guidance Raised Amid Headwinds - The Globe and Mail
Adient Looks Well Poised to Remain in the Top Two of Automotive Seating - Morningstar
Higher taxes drive Adient (NYSE: ADNT) to modest Q1 loss - Stock Titan
Adient PLC (ADNT) Q1 2026 Earnings Call Highlights: Strong Reven - GuruFocus
Adient (ADNT) Q1 2026 Earnings Call Transcript - The Globe and Mail
Adient (NYSE:ADNT) Releases Quarterly Earnings Results, Beats Expectations By $0.16 EPS - MarketBeat
Adient Q1 FY26 slides: Revenue up 4%, raises full-year outlook on strong start - Investing.com India
Adient (NYSE:ADNT) Shares Gap Up After Strong Earnings - MarketBeat
Earnings call transcript: Adient Q1 2026 beats EPS forecast, stock surges - Investing.com
Adient (ADNT) Exceeds Revenue Expectations with Strong Q1 Perfor - GuruFocus
Adient (ADNT) Increases FY26 Adjusted EBITDA Forecast - GuruFocus
Finanzdaten der Adient Plc-Aktie (ADNT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.18%
0.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):